Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
…
continue reading
This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
…
continue reading
Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.
…
continue reading
Grow Everything reveals the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, synbio, entrepreneurship, and culture an ...
…
continue reading
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
…
continue reading
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
…
continue reading
1
Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs
JMB Davis Ben-David International IP Law Firm
Podcast by JMB Davis Ben-David International IP Law Firm
…
continue reading
In the Biotech Career Coach podcast, we share valuable insights and advice for job seekers and career-minded individuals in the biotechnology and life sciences industry. From resume tips to leadership strategies, this podcast will help you navigate your job search and succeed in your career. This podcast is a production of The Collaboratory Career Hub To join our Community or access great resources, visit www.library.collaboratorycareerhub.com
…
continue reading
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
…
continue reading
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
…
continue reading
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
…
continue reading
Back of the Napkin is a podcast series from Bio-Techne that meets scientific pioneers. It goes beyond the publications to hear the untold stories from innovation corner, where ideas and discoveries are conceived.
…
continue reading
Forschungsthemen aus dem Bereich Biotechnologie und Verfahrenstechnik an der TUHH
…
continue reading
Biotech knowledge center
…
continue reading
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
…
continue reading
BioTech Nation Radio with Dr Moira Gunn
…
continue reading
Interviews with innovators at the intersections of science, data, and technology.
…
continue reading
Welcome to the biotech podcast where we talk to the leading scientists in the world about their work, their lives and fundamental questions concerning their field.
…
continue reading
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
…
continue reading
Defination Uses Various processes in Tissue - culture
…
continue reading
1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics. **TOP 10 LIFE SCIENCES PODCAST** Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market? Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commerc ...
…
continue reading
Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.
…
continue reading
Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
…
continue reading
In einer Podcast Folge wird jeweils ein Punkt einer Lernplaneinheit vorgestellt. Viele sind One-Taker meiner eigenen Biotech-Abi Vorbereitung :D Cover art photo provided by Annie Spratt on Unsplash: https://unsplash.com/@anniespratt
…
continue reading
Biotechnology for Tomorrow
…
continue reading
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
…
continue reading
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
…
continue reading
In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of biotech by speaking with some of the sharpest, most innovative minds in biotechnology and related fields.
…
continue reading
From sales to medical affairs, we will help you break into and navigate your career in the biopharma industry!
…
continue reading
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
…
continue reading
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
…
continue reading
What happens when robots, AI, and big data enter the hospital? Glenn Cohen (a professor and deputy dean at Harvard Law School) is unpacking that question in this exploration of biotechnology, ethics, medical law, and health care policy. Each week, he’ll interrogate a single technology – such as digital pills, AI-powered decision support algorithms, or digital health apps – through the lens of ethical concerns like informed consent, liability, and privacy.
…
continue reading
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
…
continue reading
1
109. Long Live Vitalia: The City Where Aging Slows and Innovation Accelerates With Niklas Anzinger
59:13
59:13
Spela senare
Spela senare
Listor
Gilla
Gillad
59:13
Karl and Erum welcome Niklas Anzinger, the visionary founder of Vitalia, a decentralized city aimed at revolutionizing biotech and longevity. Niklas discusses the need for a more efficient drug development process, proposing a shift toward safety trials and medical reciprocity that could drastically shorten the time it takes to bring life-saving th…
…
continue reading
1
[Rebroadcast] The power of natural killer cells
28:59
28:59
Spela senare
Spela senare
Listor
Gilla
Gillad
28:59
While our podcast takes a brief break, Labiotech invites you to enjoy some of our favorite episodes. We will return with a brand-new episode on January 3rd, 2025! Have an awesome holiday season! On this podcast, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D. The company has demonstrated the potential for efficacy and safety with natural …
…
continue reading
1
Pharma and Biotech Daily: Keeping You Informed on the Latest in Healthcare Innovations
4:11
4:11
Spela senare
Spela senare
Listor
Gilla
Gillad
4:11
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Pfizer announces positive results for COVID-19 vaccinePfizer has recently announced positive results from their phase 3 clinical trial for their COVID-19 vaccine. The vaccine showed over 90% effectiveness in preventing…
…
continue reading
1
Data for Good!!!... Sir Rory Collins, Oxford Professor and Principal Investigator, UK Biobank
25:34
25:34
Spela senare
Spela senare
Listor
Gilla
Gillad
25:34
Sir Rory Collins is a Professor of Medicine and Epidemiology at the University of Oxford and the Principal Investigator of the UK Biobank. With data from half a million people, it has served 30,000 scientists around the world, giving special support to young researchers and scientists in emergent countries.…
…
continue reading
1
Biotech Story Time With Tal Zaks, M.D. (Part 1)
55:25
55:25
Spela senare
Spela senare
Listor
Gilla
Gillad
55:25
We love to hear from our listeners. Send us a message. Tal Zaks, M.D. was Chief Medical Officer at Moderna before, during, and immediately following the company's headline role during the COVID pandemic. If that doesn't pique your interest about the stories he can tell, this episode of the Business of Biotech surely will. Tal is now leading a new m…
…
continue reading
1
🧬 Kate Neville - Part 4 | Balancing IP Enforcement & Licensing | Leveraging Shelved Pharma Assets | Building Resilient IP Portfolios
31:48
31:48
Spela senare
Spela senare
Listor
Gilla
Gillad
31:48
🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗 Get your unique r…
…
continue reading
1
116: Revolutionizing Biologics Development with Hyper Throughput Screening and AI with Jeremy Agresti - Part 2
16:43
16:43
Spela senare
Spela senare
Listor
Gilla
Gillad
16:43
Send us a text The intersection of artificial intelligence and biology presents immense opportunities for transforming bioprocess development. As the biotech industry continues to evolve, data-driven innovations are critical to optimizing biologics manufacturing. High-quality datasets stand at the forefront of this transformation, empowering resear…
…
continue reading
As biotech innovation accelerates across therapeutic areas organizations face complex strategic decisions about their future. In this episode of The Emerging Biotech Leader, former EMA Director Dr. Thomas Lönngren offers insights into the market dynamics and organizational requirements that will define success in 2025. Several key themes emerged fr…
…
continue reading
Dr. Nisim Perets is the co-founder and CEO of Itay&Beyond (itayandbeyond.com). An Israeli biotech startup that integrates patient-derived brain organoids with advanced AI analysis to predict drug efficacy for neurological and psychiatric disorders. Their platform aims to improve drug development by providing accurate human-based models, reducing re…
…
continue reading
1
Job Application Strategies for Biotech and Beyond
31:17
31:17
Spela senare
Spela senare
Listor
Gilla
Gillad
31:17
This week, listen to our monthly live virtual event, 'Ask Me Anything.' Attendees get insights on how to navigate job applications on LinkedIn, including strategies for contacting hiring managers and effective networking. We discuss tailoring resumes for biotech positions, transitioning from academia to industry, and navigating job market trends. I…
…
continue reading
1
AI Trends Reviewed 2024 & 2025 Predictions - Expert Insights From Top Biotech CIOs
1:30:42
1:30:42
Spela senare
Spela senare
Listor
Gilla
Gillad
1:30:42
Hi Everyone! Welcome to the Biotech Bytes by The Swan Group As we close out 2024 and look toward 2025, what lessons has AI taught us, and what can we expect in the future? Please visit our website to get more information: https://swangroup.net/ In this powerful discussion, eight biotech and technology CIOs—Bill Pierce, Ganesh Iyer, Bill Wallace, Ra…
…
continue reading
1
Unlocking the Power of AI in Microscopy with Ilya Goldberg and Reese Findley
47:32
47:32
Spela senare
Spela senare
Listor
Gilla
Gillad
47:32
In this episode of Data in Biotech, Ross Katz explores the transformative role of AI in microscopic imaging and life sciences with Ilya Goldberg, Chief Science Officer, and Reese Findley, an AI Data Scientist at ViQi. They discuss the cutting-edge applications of AI in automating high-content screening (HCS), enabling more efficient drug discovery,…
…
continue reading
1
Biotech, Blockchain, and Building Companies with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners
34:28
34:28
Spela senare
Spela senare
Listor
Gilla
Gillad
34:28
This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights o…
…
continue reading
1
Mpox- The Virus, Transmission and Treatment - John Rizk
38:10
38:10
Spela senare
Spela senare
Listor
Gilla
Gillad
38:10
In this episode of the Talking Biotech podcast, Kevin Folta interviews John Rizk, a pharmacist and epidemiologist, about M-Pox (formerly known as monkeypox). They discuss the emergence of M-Pox, its characteristics, transmission, symptoms, and recovery. The conversation also covers risk factors, diagnosis, vaccination strategies, treatment options,…
…
continue reading
1
Pharma and Biotech Daily: Your Daily Dose of Industry Updates
1:33
1:33
Spela senare
Spela senare
Listor
Gilla
Gillad
1:33
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. ## New Drug Approval: The FDA has approved a new drug for the treatment of a rare genetic disorder. This drug has shown promising results in clinical trials and is expected to provide hope for patients suffering from…
…
continue reading
1
2024: A Year of Successes and Setbacks in Biopharma
1:15
1:15
Spela senare
Spela senare
Listor
Gilla
Gillad
1:15
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world.In 2024, the biopharma industry experienced both successes and setbacks in the field of neuroscience drug development. Companies like Bristol Myers Squibb, Eli Lilly, and AbbVie saw highs and lows throughout the year. Des…
…
continue reading
1
2025 Biopharma Investment Trends and Therapeutic Advances in Pharma and Biotech
1:10
1:10
Spela senare
Spela senare
Listor
Gilla
Gillad
1:10
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.In 2025, VC funds are expected to follow the data when investing in biopharma companies, as high profile failures and long timeframes for revenue have shifted investment away from phase I. To attract VC dollars, companies m…
…
continue reading
1
Biotech Rollercoaster: Wins and Losses in the Pharma World
0:50
0:50
Spela senare
Spela senare
Listor
Gilla
Gillad
0:50
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo Nordisk's weight loss drug, cagrisema, failed to meet investor expectations of achieving 25% weight loss, causing the stock to plummet. Galectin's stock also tumbled after its lead asset missed the primary endpoint i…
…
continue reading
1
108. Sequence and Desist: Aclid's Kevin Flyangolts On Safeguarding the Bioeconomy
51:16
51:16
Spela senare
Spela senare
Listor
Gilla
Gillad
51:16
Kevin Flyangolts joins Erum and Karl to talk about the evolving landscape of biosecurity. They discuss the rapid advancements in biotechnology, the growing accessibility of synthetic DNA, and the need for robust screening systems to ensure safety in the bioeconomy. Kevin shares knowledge from his software background, explaining how tools like those…
…
continue reading
1
Looking at 2025 biotech trends with SoftBank Vision Fund
39:04
39:04
Spela senare
Spela senare
Listor
Gilla
Gillad
39:04
Our guest on the podcast this week is John Cassidy, director of life sciences and healthtech investments at SoftBank Vision Fund. Softbank Vision Fund is the world’s largest technology-focused investment fund, with $166bn assets under management, and a portfolio of more than 250 companies. In the discussion, we cover investment trends within life s…
…
continue reading
1
Pharma and Biotech Daily: Navigating Industry Shifts and Strategic Decisions
1:10
1:10
Spela senare
Spela senare
Listor
Gilla
Gillad
1:10
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Vertex Pharmaceuticals experienced a 13% decrease in its share price following the disappointing results of its non-opioid pain therapy, suzetrigine, in a Phase II trial. Meanwhile, major players like Bayer, Bristol Myers…
…
continue reading
1
Pharma and Biotech Daily: Cutting Through the Noise in the Industry
1:38
1:38
Spela senare
Spela senare
Listor
Gilla
Gillad
1:38
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Merck has entered the obesity pill race with a $2 billion deal with Hansoh, allowing them to compete in the crowded oral GLP-1 space. The FDA issued warning letters against GLP-1 compounders, and the EMA will investigate…
…
continue reading
1
Building Technology and Solving Problems!!! Dave Pacitti, President & Head of the Americas, Siemens Healthineers
20:30
20:30
Spela senare
Spela senare
Listor
Gilla
Gillad
20:30
When is a medical technology company more than a medical technology company? We’ll hear all about it when I speak with Dave Pacitti, the President and Head of the Americas at Siemens Healthineers. They’re out to solve problems bigger than the products they are known for.Av Moira Gunn
…
continue reading
1
Pharma and Biotech Update: Moderna, Merck, J&J, Regeneron, and More!
0:54
0:54
Spela senare
Spela senare
Listor
Gilla
Gillad
0:54
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Moderna faced a challenging year with declining share values, prompting analysts to recommend holding onto their stock. Meanwhile, Merck experienced setbacks in its cancer drug pipeline, leading to the termination of two…
…
continue reading
1
Pharma and Biotech Daily: The Latest in Drug Developments and Industry News
1:00
1:00
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Danish regulators have raised concerns about a rare eye disease associated with Novo Nordisk's GLP-1 drug, Ozempic, prompting a request for a formal EU review. The FTC has approved Novo Holdings' acquisition of Catalent,…
…
continue reading
1
115: Revolutionizing Biologics Development with Hyper Throughput Screening and AI with Jeremy Agresti - Part 1
19:49
19:49
Spela senare
Spela senare
Listor
Gilla
Gillad
19:49
Send us a text Bioprocess development is transforming the biotech industry, driving innovations in life-changing therapies. Success hinges on simplifying complex mechanisms and adopting advanced technologies. By integrating high-throughput screening and artificial intelligence, we can streamline workflows, reduce trial-and-error, and speed up biolo…
…
continue reading
1
A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.
52:50
52:50
Spela senare
Spela senare
Listor
Gilla
Gillad
52:50
We love to hear from our listeners. Send us a message. This past spring, Xaira Therapeutics launched with $1 billion in backing, a who's-who mashup of Silicon Valley and biopharma stars led by Marc Tessier-Lavigne in the C-suite, and a mission to develop AI-generated drugs. On this week's episode of the Business of Biotech, we're digging into the c…
…
continue reading
1
🧬Kate Neville - Part 3 | Fundamentals of IP Strategy for Biotechs | Safeguarding Discoveries & Technology | Aligning Science with Patents | Navigating Global Patent Considerations
29:53
29:53
Spela senare
Spela senare
Listor
Gilla
Gillad
29:53
🧬The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗Get your unique refe…
…
continue reading
1
Pharma and Biotech Daily: Latest News and Updates in the Industry
0:47
0:47
Spela senare
Spela senare
Listor
Gilla
Gillad
0:47
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Private equity firms Blackstone and Bain Capital are close to finalizing a potential $3 billion deal for Mitsubishi's pharma unit, Mitsubishi Tanabe Pharma. In other news, five drugs have been flagged for unjustified price …
…
continue reading
1
107. Glow Big or Go Home: Andy Bass's Journey with Glowing Oceans
1:00:55
1:00:55
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:55
Andy Bass brings the ocean's glow to your hands, turning natural wonders like bioluminescent plankton into personal and immersive experiences. From creating the Dino Pet to designing ocean-bathing exhibits, Andy shares how biology can light up creativity, spark curiosity, and inspire the next generation of conservationists. It's a conversation abou…
…
continue reading
1
Finding new treatments for peanut allergy
31:06
31:06
Spela senare
Spela senare
Listor
Gilla
Gillad
31:06
There is a constant risk of severe, potentially life-threatening allergic reactions for individuals with peanut allergies, which leads to significant physical, social, and emotional burdens. IgGenix, a clinical-stage immunology biotechnology company, recently announced the first patient dosed in its phase 1 trial evaluating IGNX001, a novel monoclo…
…
continue reading
1
Pharma and Biotech Daily: Key Updates in Drug Development and Regulatory Approvals
1:05
1:05
Spela senare
Spela senare
Listor
Gilla
Gillad
1:05
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The European Medicines Agency approved a kidney disease-related label expansion for Novo Nordisk's Ozempic, a GLP-1 drug, after a study showed a reduced risk of death by 20%. Keros suspended two arms of a hypertension stu…
…
continue reading
1
🧬Kate Neville - Part 2 | Navigating Law School as a Scientist | From Patent Agent to Lawyer | Thriving at the Intersection of Science & Law | Continuous Learning in Diverse Scientific Fields
20:50
20:50
Spela senare
Spela senare
Listor
Gilla
Gillad
20:50
🧬The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. 🔬Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 🔗Get your unique refe…
…
continue reading
1
Pharma and Biotech Daily: Latest Updates in the World of Drug Development and Deal Making
1:42
1:42
Spela senare
Spela senare
Listor
Gilla
Gillad
1:42
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.J&J and Legend have released new Phase III data for their drug Carvykti, showing nearly 90% of patients had no detectable cancer cells after treatment. This data could help them fend off competition from emerging CAR T ther…
…
continue reading
1
114: Weighing of Single-Use Bag Systems: Why Traditional Load Cells Are Holding You Back with Anders Tvegaard - Part 2
18:08
18:08
Spela senare
Spela senare
Listor
Gilla
Gillad
18:08
Send us a text Is your bioprocess facility wasting precious time and resources on traditional weighing system calibrations? In this eye-opening episode, Anders Tvegaard, COO of Eilersen Electric, reveals how digital load cell innovation is revolutionizing bioprocess monitoring and validation. Discover why weighing systems aren't the commodity techn…
…
continue reading
1
Antidepressants Should Have Diagnostics??? Dr. Amit Etkin, Founder & CEO, Alto Neuroscience
25:57
25:57
Spela senare
Spela senare
Listor
Gilla
Gillad
25:57
Major Depressive Disorder. Serious Depression. PTSD. Alto Neuroscience CEO, Dr. Amit Etkin talks about developing new and innovative drugs tied directly to each patient’s underlying biology. For every drug, there is a test...Av Moira Gunn
…
continue reading
1
Pharma and Biotech Daily: Keeping You Updated on the Latest in Healthcare Innovation
3:36
3:36
Spela senare
Spela senare
Listor
Gilla
Gillad
3:36
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##New FDA Approval for Cancer TreatmentThe FDA has recently approved a new drug for the treatment of advanced ovarian cancer. This drug has shown promising results in clinical trials, with patients experiencing longer sur…
…
continue reading
1
Accelerating Progress in Pharma and Biotech: A Closer Look at Surrogate Endpoints and Promising Therapies
2:33
2:33
Spela senare
Spela senare
Listor
Gilla
Gillad
2:33
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA's accelerated approval pathway, established in 1992, has allowed over 200 new drugs to come to market based on surrogate endpoints. While many products have later received full FDA approval, recent withdrawals lik…
…
continue reading
1
113: Weighing of Single-Use Bag Systems: Why Traditional Load Cells Are Holding You Back with Anders Tvegaard - Part 1
22:22
22:22
Spela senare
Spela senare
Listor
Gilla
Gillad
22:22
Send us a text What do furniture manufacturing and bioprocess weighing have in common? In this fascinating episode, Anders Tvegaard, COO of Eilersen Electric Digital Systems shares the remarkable story of how his company evolved from solving a furniture maker's wood humidity measurement problems to revolutionizing pharmaceutical manufacturing. Fift…
…
continue reading
1
Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski
1:03:50
1:03:50
Spela senare
Spela senare
Listor
Gilla
Gillad
1:03:50
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jerry McLaughlin, CEO and President at Life Biosciences returns for a visit, and he brought a friend in John Maslowski, newly-appointed CEO at Forge Biologics. We revisit progress at Life Biosciences, followed by a deep look into the gears that…
…
continue reading
1
🧬 Kate Neville - Part 1 | From Youngest of Six to Patent Law Pioneer | When Chemistry Sets Spark Scientific Careers | Leading Through Autonomy | Serendipitous Path from Lab Bench to IP Law
28:01
28:01
Spela senare
Spela senare
Listor
Gilla
Gillad
28:01
The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 Get your unique referra…
…
continue reading
1
Pharma and Biotech Daily: Eli Lilly's $3 Billion Investment, FDA Guidelines, and Industry Job Opportunities
0:53
0:53
Spela senare
Spela senare
Listor
Gilla
Gillad
0:53
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Eli Lilly's $3 billion investment in manufacturing capacity for tirzepatide is in the spotlight as compounding pharmacies challenge an FDA decision to end the drug shortage. Meanwhile, Amgen is making waves with a $1 billi…
…
continue reading
1
106. Ferment Your Worldview: Jason Kakoyiannis' Recipe for a Bioeconomy Boom
1:03:43
1:03:43
Spela senare
Spela senare
Listor
Gilla
Gillad
1:03:43
Karl and Erum are taking us deep into the intersection of biology, industry, and innovation with their guest, Jason Kakoyiannis. Jason is the founder of Bioscentric, advisor at Allonnia, and managing partner of Ferment! From starting his journey in the art world to leading the charge at Ferment, Jason shares how curiosity and the drive to solve com…
…
continue reading
1
Cracking the code of biotech valuations
37:43
37:43
Spela senare
Spela senare
Listor
Gilla
Gillad
37:43
ambiom is a life science commercial-advisory business development company based in the Slovakian capital of Bratislava. The company helps its corporate clients with their product strategy, in- and out-licensing efforts, including asset valuation (NPV, rNPV), M&A scouting, complex due diligence and dealmaking. ambiom also provides input on regulator…
…
continue reading
1
Pharma and Biotech Daily: Your Quick Update on Vaccine News
2:15
2:15
Spela senare
Spela senare
Listor
Gilla
Gillad
2:15
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Pfizer announces new vaccine distribution planPfizer has announced a new vaccine distribution plan that aims to reach more people in rural areas. The company will be partnering with local health departments and communi…
…
continue reading
1
🧬 Barry Ticho - Part 4 | Founding Verve Therapeutics Over Breakfast | Gene Editing for Cardiovascular Disease | Leadership Lessons From a First-Time Founder | Stoke’s Vision for RNA-Based Medicines
39:40
39:40
Spela senare
Spela senare
Listor
Gilla
Gillad
39:40
The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 Get your unique referra…
…
continue reading
1
The Latest in Pharma and Biotech: Lilly's Weight Loss Victory and Industry Updates
1:36
1:36
Spela senare
Spela senare
Listor
Gilla
Gillad
1:36
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Lilly emerged victorious in a head-to-head weight loss battle against NovoPlus, showcasing the effectiveness of tirzepatide over semaglutide. This victory has highlighted the potential of tirzepatide in promoting weight los…
…
continue reading
1
112: AI Meets Biology: Why Domain Expertise Still Rules in the Age of Large Language Models with Lars Brandén - Part 2
23:41
23:41
Spela senare
Spela senare
Listor
Gilla
Gillad
23:41
Send us a text Can artificial intelligence revolutionize drug development and reduce the staggering 90% failure rate in clinical trials? In this insightful episode, Lars Brandén, Director of Biology at Kolibri, shares his vision for the future of personalized medicine. Drawing from his extensive experience bridging academia and industry, Lars explo…
…
continue reading
1
Can AI Discover Drugs Better Than Humans?? Dr. Vimal Mehta, Co-Founder & CEO BioXcel
20:00
20:00
Spela senare
Spela senare
Listor
Gilla
Gillad
20:00
Discover how their AI technology is revolutionizing drug discovery with Dr. Vimal Mehta, Co-Founder and CEO BioXcel and how this is leading to the approval of their first drug for agitation in bipolar I and II and schizophrenia, and paving the way for new treatments.Av Moira Gunn
…
continue reading
1
Pharma and Biotech Daily: The Latest Deals and Developments in the Industry
1:14
1:14
Spela senare
Spela senare
Listor
Gilla
Gillad
1:14
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Takeda, Roche, and Gilead have recently made significant deals in the pharmaceutical industry. Takeda's investment of up to $1.3 billion in Keros' blood cancer anemia drug is making waves, potentially challenging Bristol …
…
continue reading